CN1304417C - 用于lhrh拮抗剂合成的中间体,它们的生产方法和lhrh拮抗剂的生产方法 - Google Patents

用于lhrh拮抗剂合成的中间体,它们的生产方法和lhrh拮抗剂的生产方法 Download PDF

Info

Publication number
CN1304417C
CN1304417C CNB028283813A CN02828381A CN1304417C CN 1304417 C CN1304417 C CN 1304417C CN B028283813 A CNB028283813 A CN B028283813A CN 02828381 A CN02828381 A CN 02828381A CN 1304417 C CN1304417 C CN 1304417C
Authority
CN
China
Prior art keywords
boc
4clphe
3pal
2nal
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028283813A
Other languages
English (en)
Chinese (zh)
Other versions
CN1622954A (zh
Inventor
J·H·拉斯姆森
P·H·拉斯姆森
W·O·瓦克斯
S·汉森
J·弗姆斯加德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CARLBIOTECH Ltd AS
Original Assignee
CARLBIOTECH Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CARLBIOTECH Ltd AS filed Critical CARLBIOTECH Ltd AS
Publication of CN1622954A publication Critical patent/CN1622954A/zh
Application granted granted Critical
Publication of CN1304417C publication Critical patent/CN1304417C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CNB028283813A 2001-12-29 2002-12-23 用于lhrh拮抗剂合成的中间体,它们的生产方法和lhrh拮抗剂的生产方法 Expired - Fee Related CN1304417C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE01044635 2001-12-29
SE0104463A SE0104463D0 (sv) 2001-12-29 2001-12-29 Mellanprodukter för syntes af LHRH-antagonister, sätt att framställa dem och sätt för framställning av LHRH-antagonister

Publications (2)

Publication Number Publication Date
CN1622954A CN1622954A (zh) 2005-06-01
CN1304417C true CN1304417C (zh) 2007-03-14

Family

ID=20286557

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028283813A Expired - Fee Related CN1304417C (zh) 2001-12-29 2002-12-23 用于lhrh拮抗剂合成的中间体,它们的生产方法和lhrh拮抗剂的生产方法

Country Status (21)

Country Link
US (2) US20050124788A1 (enExample)
EP (2) EP1630169B1 (enExample)
JP (1) JP4272529B2 (enExample)
KR (1) KR100844520B1 (enExample)
CN (1) CN1304417C (enExample)
AT (2) ATE342913T1 (enExample)
AU (1) AU2002348749B2 (enExample)
CA (1) CA2471723C (enExample)
CY (2) CY1107580T1 (enExample)
DE (2) DE60215544T2 (enExample)
DK (2) DK1465917T3 (enExample)
ES (2) ES2296050T3 (enExample)
IL (2) IL162788A0 (enExample)
NO (1) NO330129B1 (enExample)
NZ (1) NZ534245A (enExample)
PT (2) PT1630169E (enExample)
RU (1) RU2307125C2 (enExample)
SE (1) SE0104463D0 (enExample)
SI (1) SI1630169T1 (enExample)
WO (1) WO2003055902A1 (enExample)
ZA (1) ZA200405136B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4407322B2 (ja) * 2004-03-09 2010-02-03 味の素株式会社 ペプチドの製造方法
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
TWI442932B (zh) 2008-02-11 2014-07-01 Ferring Int Ct Sa 以ＧｎＲＨ拮抗劑治療攝護腺癌的方法
EP2447276A1 (en) * 2010-10-27 2012-05-02 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
RS55457B1 (sr) 2010-10-27 2017-04-28 Ferring Bv Postupak za proizvodnju degareliksa i njegovih intermedijara
AR092840A1 (es) 2012-06-01 2015-05-06 Ferring Bv Elaboracion de degarelix

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2039395A1 (en) * 1990-03-30 1991-10-01 Arthur R. Doumaux, Jr. Selective production of linear pentaethylenehexamine and hydroxyethyldiethylenetriamine
US5710246A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process for intermediates for the synthesis of LHRH antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098777A (en) * 1977-03-14 1978-07-04 Merck & Co., Inc. Process for the preparation of pyroglutamyl-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn
SU1623166A1 (ru) * 1989-04-03 1994-02-15 Институт биоорганической химии АН БССР Нейтропептиды, обладающие поведенческой активностью
JPH05508859A (ja) * 1990-07-24 1993-12-09 イーストマン コダック カンパニー ペプチド合成方法
US6235734B1 (en) * 1996-10-30 2001-05-22 Pfizer Inc Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
DE19941248A1 (de) 1998-09-01 2000-03-02 Asta Medica Ag Peptide mit N-substituierten Glycingruppen sowie diese enthaltende Arzneimittel zur Behandlung hormonabhängiger Tumore

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2039395A1 (en) * 1990-03-30 1991-10-01 Arthur R. Doumaux, Jr. Selective production of linear pentaethylenehexamine and hydroxyethyldiethylenetriamine
US5710246A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process for intermediates for the synthesis of LHRH antagonists

Also Published As

Publication number Publication date
DE60215544T2 (de) 2007-08-30
KR100844520B1 (ko) 2008-07-08
CA2471723C (en) 2011-02-15
ATE342913T1 (de) 2006-11-15
DE60215544D1 (de) 2006-11-30
IL162788A (en) 2010-12-30
RU2004119964A (ru) 2006-01-10
JP4272529B2 (ja) 2009-06-03
US20080306242A1 (en) 2008-12-11
DK1630169T3 (da) 2008-01-02
PT1465917E (pt) 2007-01-31
EP1630169A2 (en) 2006-03-01
AU2002348749B2 (en) 2008-09-04
AU2002348749A1 (en) 2003-07-15
HK1075052A1 (en) 2005-12-02
EP1630169A3 (en) 2006-03-15
SI1630169T1 (sl) 2008-04-30
CY1107025T1 (el) 2012-09-26
NZ534245A (en) 2007-05-31
ES2296050T3 (es) 2008-04-16
DK1465917T3 (da) 2007-02-19
NO330129B1 (no) 2011-02-21
EP1465917A1 (en) 2004-10-13
ES2275012T3 (es) 2007-06-01
CN1622954A (zh) 2005-06-01
SE0104463D0 (sv) 2001-12-29
IL162788A0 (en) 2005-11-20
EP1630169B1 (en) 2007-08-29
RU2307125C2 (ru) 2007-09-27
DE60222189D1 (de) 2007-10-11
DE60222189T2 (de) 2008-06-19
WO2003055902A1 (en) 2003-07-10
CY1107580T1 (el) 2013-03-13
PT1630169E (pt) 2007-12-06
US8173770B2 (en) 2012-05-08
US20050124788A1 (en) 2005-06-09
CA2471723A1 (en) 2003-07-10
EP1465917B1 (en) 2006-10-18
ZA200405136B (en) 2005-07-27
KR20040090965A (ko) 2004-10-27
NO20043047L (no) 2004-08-30
ATE371666T1 (de) 2007-09-15
JP2005516962A (ja) 2005-06-09

Similar Documents

Publication Publication Date Title
US8828938B2 (en) Method for the manufacture of degarelix
JP6007187B2 (ja) デガレリクスおよびその中間体を製造する方法
JP2542362B2 (ja) 新規ハロ低級アルキルグアニジノ置換アミノ酸化合物およびその製法
EP2119724A1 (en) Solid-phase process foor the preparation of goserelin
JP6703669B2 (ja) リュープロレリンの製造方法
WO2017114238A1 (zh) 一种合成Etelcalcetide的方法
WO2009003666A1 (en) Process for the production of pramlintide
CN109575109B (zh) 片段缩合制备地加瑞克的方法
AU2014282839B9 (en) Peptide-resin conjugate and use thereof
US8173770B2 (en) Intermediates for LHRH antagonist synthesis, process for the production, and process for LHRH antagonist production
US9150615B2 (en) Process for the preparation of leuprolide and its pharmaceutically acceptable salts
WO2005087794A1 (en) Process for octreotide synthesis
HK1075052B (en) Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production
CN111233980A (zh) 一种戈舍瑞林的片段法合成方法
CN107955061A (zh) 地加瑞克关键中间体的制备方法
WO2020259714A1 (zh) 一种地加瑞克的制备方法
WO2019095592A1 (zh) 一种Reltecimod的液相制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1075052

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1075052

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070314

Termination date: 20191223

CF01 Termination of patent right due to non-payment of annual fee